Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02611154 · ClinicalTrials.gov registry record · Phase 4
Intranasal Delivery of Testosterone and Its Effect on Doping Markers
A Phase 4 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT02611154 is a Phase 4 study that has completed, run by University of Utah. The registered enrollment target is 5 participants.
The verdict
NCT02611154, a Phase 4 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
Hypothesis: Intranasal administration of exogenous testosterone results in a characteristic profile during anti-doping testing, which is different than the profile seen when testosterone is administered into muscle, on skin or under the tongue. Objective: The investigators aim to characterize the unique steroid doping profile following administration of intranasal testosterone to healthy, active volunteer subjects.
Interventions
- DRUG Testosterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-11-18 |
| Est. Completion | 2016-01-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02611154
The ClinicalTrials.gov registry entry for NCT02611154 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Testosterone is the first listed.
NCT02611154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02611154 about?
NCT02611154 is a clinical study titled "Intranasal Delivery of Testosterone and Its Effect on Doping Markers". Hypothesis: Intranasal administration of exogenous testosterone results in a characteristic profile during anti-doping testing, which is different than the profile seen when testosterone is administered into muscle, on skin or under the tongue. Objective: The investigators aim to characterize the u...
What is the current status of trial NCT02611154?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2015-11-18. Estimated completion is 2016-01-19.
What interventions are being tested in trial NCT02611154?
The interventions under investigation include: Testosterone (DRUG).
Who is sponsoring clinical trial NCT02611154?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.